| 5-FU | 5-Fluorouracil |
| ACC | Adenoid Cystic Carcinoma |
| ACL | Lung Adenocarcinoma |
| ADAM | A Disintegrin and Metalloproteinase |
| AIF | Apoptosis-Inducing Factor |
| ALDH | Aldehyde Dehydrogenase |
| ALL | Acute Lymphoblastic Leukemia |
| AML | Acute Myeloid Leukemia |
| ANK | Ankyrin Repeats |
| APP | Amyloid Precursor Proteins |
| ARA-C | Cytarabine |
| ASCL1 | Achaete-Scute Homolog 1 |
| ATP | Adenosine Triphosphate |
| B-ALL | B-cell Acute Lymphoblastic Leukemia |
| BBB | Blood−Brain Barrier |
| BBC3 | BCL-Binding Component 3 |
| BCL | B-cell lymphoma |
| BMF | BCL2-Modifying Factor |
| BRD4 | Bromodomain-containing protein 4 |
| BTK | Bruton Tyrosine Kinase |
| CBF1 | C-repeat/DRE-Binding Factor 1 |
| CD | Cluster of Differentiation |
| CI | Combination Index |
| CLL | Chronic Lymphocytic Leukemia |
| CNS | Central Nervous System |
| CRC | Colorectal Cancer |
| CR | Complete Response |
| CSC | Cancer Stem Cell |
| CSL | CBF-1/RBP-Jκ/Suppressor of Hairless and Lag-1 |
| CT | Clinical Trial |
| CtBP | C-Terminal Binding Protein |
| CtIP | CtBP Interacting Protein |
| DAC | 5-aza-2′deoxycytidine |
| DGC | Diffuse Gastric Cancer |
| DHFR | Dihydrofolate Reductase |
| DLK | Delta-like Homolog |
| DLL | Delta-like Ligand |
| DN | Double Negative |
| DNMT | DNA Methyltransferase |
| DSL | Delta/Serrate/Lag2 ligands |
| EAC | Esophageal Adenocarcinoma |
| EC | Endothelial Cells |
| EGF | Epidermal Growth Factor |
| EGFR | Epidermal Growth Factor Receptor |
| EMT | Epithelial-Mesenchymal Transition |
| ER | Endoplasmic Reticulum |
| ERα+ | Estrogen Receptor α-Positive |
| ERK | Extracellular Signal-Regulated Kinase |
| ESCC | Esophagus Squamous Cell Carcinoma |
| EZH2 | Enhancer of Zeste Homolog 2 |
| FOLFIRI | Folinic Acid/5-FU/Irinotecan |
| FBXW7 | F-Box and WD Repeat Domain Containing 7 |
| FDA | Food and Drug Administration |
| FGFR | Fibroblast Growth Factor Receptor |
| GBM | Glioblastoma Multiforme |
| GCT | Gastric Carcinoid Tumor |
| GI | Gastrointestinal |
| GR | Glucocorticoid Receptor |
| GS | Gamma-Secretase Complex |
| GSC | Glioma Stem-Like Cells |
| GSI | Gamma-Secretase Inhibitor |
| GSK-3 | Glycogen Synthase Kinase-3 |
| H | Histone |
| HAT | Histone Acetyltransferase |
| HCC | Hepatocellular Carcinoma |
| HD | Heterodimerization Domain |
| HDAC | Histone Deacetylase |
| HER | Human Epidermal Growth Factor Receptor |
| HES | Hairy/Enhancer of Split |
| HIF | Hypoxia Inducible Factor |
| HMT | Histone Methyltransferase |
| HNSCC | Head and Neck Squamous Cell Carcinoma |
| HNK | Honokiol |
| HPV | Human Papillomavirus |
| HSC | Hematopoietic Stem Cells |
| IC50 | Half-Inhibitory Concentration |
| IGF1R | Insulin-like Growth Factor 1 |
| IKK | Inhibitor of Nuclear Factor-κB (IκB) Kinase |
| IL | Interleukin |
| IMR-1 | Inhibitor of Mastermind Recruitment-1 |
| IXN | Isoxanthohumol |
| JMJD3 | Jumonji Domain-Containing Protein 3 |
| KDM | Lysine Demethylase |
| KMT | Lysine Methyltransferase |
| LCNEC | Large-Cell Neuroendocrine Carcinoma |
| LIC | Leukemia-Initiating Cells |
| LiCl | Lithium Chloride |
| LNR | Lin12-Notch Repeats |
| LSC | Leukemia Stem Cells |
| LSCC | Lung Squamous Cell Carcinoma |
| LSD1 | Lysine Demethylase 1 |
| mAb | Monoclonal Antibody |
| MAGP | Microfibril-Associated Glycoprotein |
| MAM | Mastermind |
| MAML | Mastermind-like |
| MAPK | Mitogen-Activated Protein Kinase |
| MCL1 | Myeloid Cell Leukemia Sequence 1 |
| MDR | Multidrug Resistance |
| miR | MicroRNA |
| MM | Multiple Myeloma |
| MMP | Matrix Metallopeptidase |
| MRI | Magnetic Resonance Imaging |
| MRP1 | Multidrug-Resistance-Associated Protein-1 |
| MTC | Medullary Thyroid Cancer |
| mTOR | Mammalian Target of Rapamycin |
| NAC | N-Acetylcysteine |
| N1IC | Notch1 Intracellular Domain |
| N2IC | Notch2 Intracellular Domain |
| N3IC | Notch3 Intracellular Domain |
| N4IC | Notch4 Intracellular Domain |
| NEC | Notch Extracellular Domain |
| NET | Neuroendocrine Tumor |
| NEXT | Notch Extracellular Truncation |
| NF-κB | Nuclear Factor κB |
| NHD | Notch Heterodimerization Domain |
| NIC | Notch Intracellular Domain |
| NR2F6 | Nuclear Receptor Subfamily Group F Member 6 |
| NRF2 | Nuclear Factor Erythroid 2-Related Factor 2 |
| NRR | Negative Regulatory Region |
| NSC | Neural Stem Cells |
| NSCLC | Non-Small-Cell Lung Cancer |
| NTC | Notch Transcription Complex |
| NTM | Notch Transmembrane−intracellular Fragment |
| OR | Objective Response |
| ORR | Objective Response Rate |
| OS | Overall Survival |
| PARP | Poly (ADP-Ribose) Polymerase |
| PD | Progressive Disease |
| PDAC | Pancreatic Ductal Adenocarcinoma |
| PDGF | Platelet-Derived Growth Factor |
| PDX | Patient-Derived Xenograft |
| PEST | Proline (P)/Glutamic Acid (E)/Serine (S)/Threonine (T)-Rich Motif |
| PFKFB2 | 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 2 |
| PFS | Progression-Free Survival |
| PHF8 | Histone Lysine De-methylase PHF8 |
| PI3K | Phosphatidylinositol-3-kinase |
| Pofut1 | O-fucosyltransferase1 |
| PR | Partial Response |
| PRC2 | Polycomb-Repressive Complex 2 |
| PSEN | Presenilin |
| PTEN | Phosphatase and Tension Homolog Deleted on Chromosome 10 |
| PTMs | Post-Translational Modifications |
| RAM | RBP-jκ Associated Molecule |
| RIN1 | RBP-jκ INhibitor-1 |
| RISC | RNA-Induced Silencing Complex |
| ROS | Reactive Oxygen Species |
| Rova-T | Rovalpituzumab Tesirine |
| RBP-jκ | Recombination Signal Binding Protein for Immunoglobulin Kappa J Region |
| RCT | Randomized Clinical Trial |
| RT | Radiotherapy |
| SCC | Squamous Cell Carcinoma |
| SCFFbxw7 | S-phase-Kinase-Associated Protein1(SKP1) Cullin1(CUL1)-F-box |
| SCLC | Small-Cell Lung Cancer |
| SD | Stable Disease |
| SERCA | Sarco(endo)plasmic Reticulum Ca+2 ATPase |
| SHARP | SMRT/HDAC1-Associated Repressor Protein |
| siRNA | Silencing RNA |
| SSCC | Skin Squamous Cell Carcinoma |
| STAT | SRA Taxonomy Analysis Tool |
| TAD | Transactivation Domain |
| T-ALL | T-cell Acute Lymphoblastic Leukemia |
| TCR | T-cell Receptor |
| TF | Transcription Factor |
| TG | Thapsigargin |
| TGF | Transforming Growth Factor |
| T-ISC | Tumor-Initiating Stem Cells |
| TMZ | Temozolomide |
| TNBC | Triple-Negative Breast Cancer |
| TS | Thymidylate Synthase |
| UTX | Ubiquitously Transcribed Tetratricopeptide Repeat X-linked Protein |
| VEGF | Vascular Endothelial Growth Factor |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| VPA | Valproic Acid |
| WA | Withaferin A |
| WT | Wild-Type |
| XN | Xanthohumol |
| ZEB1 | Zinc Finger E-Box Binding Homeobox 1 |